157 related articles for article (PubMed ID: 32131555)
1. Fluorescence Differentiation of ATP-related Multiple Enzymatic Activities in Synovial Fluid as a Marker of Calcium Pyrophosphate Deposition Disease using Kyoto Green.
Yongwattana N; Mekjinda N; Tawonsawatruk T; Hamachi I; Ojida A; Wongkongkatep J
Molecules; 2020 Mar; 25(5):. PubMed ID: 32131555
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors.
al-Rashida M; Iqbal J
Med Res Rev; 2014 Jul; 34(4):703-43. PubMed ID: 24115166
[TBL] [Abstract][Full Text] [Related]
3. Adenosine triphosphate pyrophosphohydrolase and neutral inorganic pyrophosphatase in pathologic joint fluids. Elevated pyrophosphohydrolase in calcium pyrophosphate dihydrate crystal deposition disease.
Rachow JW; Ryan LM
Arthritis Rheum; 1985 Nov; 28(11):1283-8. PubMed ID: 2998408
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of nucleotide pyrophosphatase/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug.
Danino O; Svetitsky S; Kenigsberg S; Levin A; Journo S; Gold A; Drexler M; Snir N; Elkayam O; Fischer B; Arad U
Rheumatology (Oxford); 2018 Aug; 57(8):1472-1480. PubMed ID: 29688536
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of alkaline phosphatase by cysteine: implications for calcium pyrophosphate dihydrate crystal deposition disease.
So PP; Tsui FW; Vieth R; Tupy JH; Pritzker KP
J Rheumatol; 2007 Jun; 34(6):1313-22. PubMed ID: 17516619
[TBL] [Abstract][Full Text] [Related]
6. Inorganic pyrophosphate generation from adenosine triphosphate by cell-free human synovial fluid.
Park W; Masuda I; Cardenal-Escarcena A; Palmer DL; McCarty DJ
J Rheumatol; 1996 Apr; 23(4):665-71. PubMed ID: 8730124
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Extracellular Pyrophosphate Increases in Vascular Smooth Muscle Cells During Phosphate-Induced Calcification.
Villa-Bellosta R
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2137-2147. PubMed ID: 30002059
[TBL] [Abstract][Full Text] [Related]
8. Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation.
Orriss IR; Key ML; Hajjawi MO; Arnett TR
PLoS One; 2013; 8(7):e69057. PubMed ID: 23874866
[TBL] [Abstract][Full Text] [Related]
9. Ectonucleotidases and nucleotide/nucleoside transporters as pharmacological targets for neurological disorders.
Bonan CD
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):739-50. PubMed ID: 22963442
[TBL] [Abstract][Full Text] [Related]
10. Synovial fluid inorganic pyrophosphate concentration and nucleotide pyrophosphohydrolase activity in basic calcium phosphate deposition arthropathy and Milwaukee shoulder syndrome.
Rachow JW; Ryan LM; McCarty DJ; Halverson PC
Arthritis Rheum; 1988 Mar; 31(3):408-13. PubMed ID: 2833903
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide pyrophosphohydrolase in human synovial fluid.
Masuda I; Cardenal A; Ono W; Hamada J; Haas AL; McCarty DJ
J Rheumatol; 1997 Aug; 24(8):1588-94. PubMed ID: 9263156
[TBL] [Abstract][Full Text] [Related]
12. Mercaptopyruvate inhibits tissue-nonspecific alkaline phosphatase and calcium pyrophosphate dihydrate crystal dissolution.
Kannampuzha JV; Tupy JH; Pritzker KP
J Rheumatol; 2009 Dec; 36(12):2758-65. PubMed ID: 19884277
[TBL] [Abstract][Full Text] [Related]
13. Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases.
Gijsbers R; Ceulemans H; Stalmans W; Bollen M
J Biol Chem; 2001 Jan; 276(2):1361-8. PubMed ID: 11027689
[TBL] [Abstract][Full Text] [Related]
14. Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate.
Ryan LM; Rachow JW; McCarty DJ
J Rheumatol; 1991 May; 18(5):716-20. PubMed ID: 1650841
[TBL] [Abstract][Full Text] [Related]
15. Exploration of carboxy pyrazole derivatives: Synthesis, alkaline phosphatase, nucleotide pyrophosphatase/phosphodiesterase and nucleoside triphosphate diphosphohydrolase inhibition studies with potential anticancer profile.
Channar PA; Afzal S; Ejaz SA; Saeed A; Larik FA; Mahesar PA; Lecka J; Sévigny J; Erben MF; Iqbal J
Eur J Med Chem; 2018 Aug; 156():461-478. PubMed ID: 30015078
[TBL] [Abstract][Full Text] [Related]
16. Inorganic pyrophosphatase induces type I collagen in osteoblasts.
Polewski MD; Johnson KA; Foster M; Millán JL; Terkeltaub R
Bone; 2010 Jan; 46(1):81-90. PubMed ID: 19733704
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the role of ENPP1 and TNAP genes in chondrocalcinosis.
Zhang Y; Brown MA; Peach C; Russell G; Wordsworth BP
Rheumatology (Oxford); 2007 Apr; 46(4):586-9. PubMed ID: 17043047
[TBL] [Abstract][Full Text] [Related]
18. Inorganic pyrophosphate, nucleoside triphosphate pyrophosphatase, and cartilage fragments in normal human synovial fluid.
Hamilton E; Pattrick M; Doherty M
Br J Rheumatol; 1991 Aug; 30(4):260-4. PubMed ID: 1650620
[TBL] [Abstract][Full Text] [Related]
19. Effects of pH on the production of phosphate and pyrophosphate by matrix vesicles' biomimetics.
Simão AM; Bolean M; Hoylaerts MF; Millán JL; Ciancaglini P
Calcif Tissue Int; 2013 Sep; 93(3):222-32. PubMed ID: 23942722
[TBL] [Abstract][Full Text] [Related]
20. Histone Deacetylase Inhibitors Downregulate Calcium Pyrophosphate Crystal Formation in Human Articular Chondrocytes.
Chang CC; Lee KL; Chan TS; Chung CC; Liang YC
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
